We are live on
!
Find out more
FC
Forte Capital Portfolio holdings
AUM
$930M
1-Year Est. Return
24.11%
This Fund
S&P 500
This Quarter
Est. Return
+9.2%
1 Year Est. Return
+24.11%
3 Year Est. Return
+98.33%
5 Year Est. Return
+137.98%
10 Year Est. Return
+353.08%
AUM
$353M
AUM Growth
+$29.4M
(+9.1%)
Cap. Flow
+$2.63M
Cap. Flow
% of AUM
0.74%
Top 10 Holdings %
Top 10 Hldgs %
42.58%
Holding
94
New
2
Increased
31
Reduced
53
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MASI
Masimo
MASI
|
+$3.16M |
| 2 |
Vanguard Small-Cap ETF
VB
|
+$1.92M |
| 3 |
CVS Health
CVS
|
+$1.41M |
| 4 |
Vanguard Growth ETF
VUG
|
+$1.34M |
| 5 |
Vanguard Value ETF
VTV
|
+$1.23M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Small-Cap Value ETF
VBR
|
+$1.86M |
| 2 |
Vanguard Mid-Cap Value ETF
VOE
|
+$1.53M |
| 3 |
Invesco S&P 500 Pure Growth ETF
RPG
|
+$1.23M |
| 4 |
Pfizer
PFE
|
+$888K |
| 5 |
Apple
AAPL
|
+$832K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.32% |
| 2 | Financials | 14.23% |
| 3 | Healthcare | 10.56% |
| 4 | Consumer Discretionary | 7.21% |
| 5 | Industrials | 6.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Colgate-Palmolive
CL
$75.6B
| $821K | 0.23% |
11,922
-700
| -6% | -$47.7K |
|
77
Monro
MNRO
$536M
| $806K | 0.23% |
10,311
-192
| -2% | -$14.5K |
|
|
MXIM
78
DELISTED
Maxim Integrated Products
MXIM
| $799K | 0.23% |
12,985
-345
| -3% | -$20.1K |
|
79
Altria Group
MO
$125B
| $752K | 0.21% |
15,065
-5,330
| -26% | -$251K |
|
80
Cognizant
CTSH
$23.3B
| $695K | 0.2% |
11,210
-950
| -8% | -$58.7K |
|
81
International Paper
IP
$23.2B
| $683K | 0.19% |
15,652
-2,656
| -15% | -$111K |
|
82
Oracle
ORCL
$335B
| $634K | 0.18% |
11,962
-94
| -0.8% | -$5.17K |
|
83
Bank of America
BAC
$436B
| $608K | 0.17% |
17,267
-8,050
| -32% | -$260K |
|
84
First Mid Bancshares
FMBH
$1.37B
| $536K | 0.15% |
15,200
| – | – |
|
85
iShares Currency Hedged MSCI EAFE ETF
HEFA
$7.46B
| $433K | 0.12% |
14,185
| – | – |
|
86
GE Aerospace
GE
$380B
| $395K | 0.11% |
7,108
-1,688
| -19% | -$87.2K |
|
87
Enterprise Products Partners
EPD
$83.3B
| $389K | 0.11% |
13,812
-1,006
| -7% | -$27.3K |
|
88
Corning
GLW
$106B
| $319K | 0.09% |
10,971
-3,657
| -25% | -$106K |
|
89
Kinder Morgan
KMI
$71.1B
| $223K | 0.06% |
10,552
-70
| -0.7% | -$1.42K |
|
90
Core Laboratories
CLB
$517M
| – | – |
-15,546
| Closed | -$725K |
|
91
Intel
INTC
$438B
| – | – |
-10,263
| Closed | -$529K |
|
|
92
Pfizer
PFE
$143B
| – | – |
-26,045
| Closed | -$888K |
|
93
Philip Morris
PM
$314B
| – | – |
-10,851
| Closed | -$824K |
|
|
94
Vanguard Small-Cap Value ETF
VBR
$37.5B
| – | – |
-14,421
| Closed | -$1.86M |
|
Similar funds
PP
SC
CCM
BWA
SAF
NRD
CCP
ECM
Forte Capital's Q4 2019 Portfolio in Review
As of Q4 2019, Forte Capital held 94 positions worth $353M, up 9.1% from $324M the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Forte Capital's Q4 2019 filing shows 2 new, 31 increased, 53 reduced and 5 closed positions. Its largest new stake was Masimo: 21,005 shares worth $3.32M. The largest sale was Vanguard Small-Cap Value ETF, an estimated $1.86M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- Forte Capital's largest Q4 2019 buy was Masimo: 21,005 shares worth $3.32M.
- Forte Capital added most to CVS Health in Q4 2019, an estimated $1.41M increase.
- Forte Capital's biggest Q4 2019 reduction was Vanguard Mid-Cap Value ETF, cutting an estimated $1.53M.
- Forte Capital fully exited Vanguard Small-Cap Value ETF in Q4 2019, selling an estimated $1.86M.
- Forte Capital's ten largest holdings make up 43% of its $353M portfolio in Q4 2019.
- Forte Capital opened 2 new positions and closed 5 in Q4 2019.
- Forte Capital's portfolio value rose 9.1% quarter-over-quarter to $353M.
Based on Forte Capital's 13F filing for Q4 2019, filed 10 Jan 2020.